Michaels, SH, et al.
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine
1998; 339: 405–406.
Braitstein, P, et al.
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet
2006; 367: 817–824.
Zhang, F, et al.
Five-year outcomes of the China National Free Antiretroviral Treatment Program. Annals of Internal Medicine
2009; 151: 241–252.
Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet
2008, 372: 293–299.
Ministry of Health, People's Republic of China, Joint United Nations Programme on HIV/AIDS, World Health Organization. 2011 Estimates for the HIV/AIDS epidemic in China. Beijing: Ministry of Health of China, 2012.
Zhang, F, et al.
The Chinese free antiretroviral treatment program: challenges and responses. AIDS
2007; 21: 143–148.
Zhang, F, et al.
The effect of highly active antiretroviral therapy on mortality among HIV-infected former plasma donors in China. Clinical Infectious Diseases
2008; 47: 825–833.
Dou, Z, et al.
HIV-infected former plasma donors in rural Central China: from infection to survival outcomes, 1985–2008. PLoS One
2010; 5: 13737.
Hirsch, MS, et al.
Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society – USA Panel. Journal of the American Medical Association
1998; 279: 1984–1991.
Tamalet, C, et al.
Resistance of HIV-1 to multiple antiretroviral drugs in France: a 6-year survey (1997–2002) based on an analysis of over 7000 genotypes. AIDS
2003; 17: 2383–2388.
Bennett, DE, et al.
Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antiviral Therapy
2008; 13: 25–36.
Si, X, et al.
Prevalence of drug resistance mutations among antiretroviral drug-naive HIV-1-infected patients in China [in Chinese]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi
2004; 18: 308–311.
Liao, L, et al.
The prevalence of transmitted antiretroviral drug resistance in treatment-naive HIV-infected individuals in China. Journal of Acquired Immune Deficiency Syndromes
2010; 53: 10–14.
Zhang, J, et al.
Surveillance of transmitted HIV type 1 drug resistance in newly diagnosed HIV type 1-infected patients in Shandong Province, China. AIDS Research and Human Retroviruses
2010; 26: 99–103.
Ye, JR, et al.
The prevalence of drug resistance mutations among treatment-naive HIV-infected individuals in Beijing, China. AIDS Research and Human Retroviruses
2012; 28: 418–423.
Su, Q, et al.
HIV type 1 subtypes based on the pol gene and drug resistance mutations among antiretroviral-naive patients from Guangxi, Southern China. AIDS Research and Human Retroviruses
2012; 28: 725–728.
Han, X, et al.
Genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV/AIDS patients living in Liaoning Province, China: baseline prevalence and subtype-specific difference. AIDS Research and Human Retroviruses
2007; 23: 357–364.
Chen, M, et al.
Genetic diversity and drug resistance among newly diagnosed and antiretroviral treatment-naive HIV-infected individuals in western Yunnan: a hot area of viral recombination in China. BMC Infectious Diseases
2012; 12: 382.
Wang, X, et al.
Short communication: emerging transmitted HIV type 1 drug resistance mutations among patients prior to start of first-line antiretroviral therapy in middle and low prevalence sites in China. AIDS Research and Human Retroviruses
2012; 28: 1637–1639.
Chen, S, et al.
Molecular epidemiology of human immunodeficiency virus type 1 in Guangdong province of southern China. PLoS One
2012; 7: e48747.
Zhong, P, et al.
Genetic diversity and drug resistance of human immunodeficiency virus type 1 (HIV-1) strains circulating in Shanghai. AIDS Research and Human Retroviruses
2007; 23: 847–856.
Wang, JQ, et al.
Study of drug resistance among 78 antiretroviral treatment-naive patients with HIV-1 subtype B infection in central China. Drug Discoveries & Therapeutics
2007; 1: 86–88.
Liao, L, et al.
Surveys of transmitted HIV drug resistance in 7 geographic regions in China, 2008–2009. Clinical Infectious Diseases
2012; 54: 320–323.
Li, L, et al.
Different distribution of HIV-1 subtype and drug resistance were found among treatment naïve individuals in Henan, Guangxi, and Yunnan Province of China. PLoS One
2013; 8: e75777.
Lin, H, et al.
Changes in sexual behaviors among HIV-infected individuals after their HIV diagnosis in a rural prefecture of Eastern China. PLoS One
2013; 8: e59575.
Bennett, DE, et al.
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One
2009; 4: 4724.
Myatt, M, Bennett, DE. A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settings. Antiviral Therapy
2008; 13: 37–48.
Casado, JL, et al.
Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen. AIDS
2000; 14: 1–7.
Shulman, N, Winters, M. A review of HIV-1 resistance to the nucleoside and nucleotide inhibitors. Current Drug Targets – Infectious Disorders
2003; 3: 273–281.
Cheung, PK, Wynhoven, B, Harrigan, PR. 2004: which HIV-1 drug resistance mutations are common in clinical practice?
2004; 6: 107–116.
Metzner, KJ, et al.
Detection of minor populations of drug resistant HIV-1 in acute seroconverters. AIDS
2005; 19: 1819–1825.
Birk, M, Sönnerborg, A. Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment-naive patients. AIDS
1998; 12: 2369–2375.
Hammond, J, et al.
Mutations in retroviral genes associated with drug resistance. In: Human Retroviruses and AIDS, Part III. Los Alamos National Laboratory, Los Alamos, NM, 1998, pp. 36–79.
de Felipe, B, et al.
Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000–2010. Virology Journal
2011; 8: 416.
Nadembega, WM, et al.
Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso. Journal of Medical Virology
2006; 78: 1385–1391.
Tee, KK, Kamarulzaman, A, Ng, KP. Short communication: low prevalence of genotypic drug resistance mutations among antiretroviral-naive HIV type 1 patients in Malaysia. AIDS Research and Human Retroviruses
2006; 22: 121–124.
Liu, J, et al.
Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China. Archives of Virology
2007; 152: 1799–1805.